biotech

Showing 15 posts of 861 posts found.

simon-stevens

NHS Chief in high-stakes gambit to boost funding in autumn budget

November 9, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

It speaks to the desperation of the funding crisis for the NHS that Chief Executive of the NHS, Simon Stevens, …

gsk_wall

GSK indicates a return to oncology by appointing Roche veteran

November 9, 2017
Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical

GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …

promotional_banner

The End Game: Payer Engagement Webinar

November 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …

cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017
Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …

doctor_notes

Clinical trials still have a problem with ethnic minorities

November 8, 2017
Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical

Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …

mosquito

Breathalyser for malaria shows promise in trials

November 7, 2017
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …

china_block_001_takeda

Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial

November 7, 2017
Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical

Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …

addyi-prescription

Valeant backs away from female libido pill

November 7, 2017
Manufacturing and Production, Sales and Marketing Addyi, Valeant, biotech, drugs, pharma, pharmaceutical

Only two years ago, Valeant was so keen to get involved with a pill reported to increase the female libido …

window-2387518_960_720

Clinical trial transparency: Letting the light in

November 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …

merckkgaahq

Merck KGaA posts promising osteoarthritis data

November 6, 2017
Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …

eye_2

Valeant begins long comeback trail with FDA approval

November 6, 2017
Sales and Marketing Valeant, Vyzulta, biotech, drugs, pharma, pharmaceutical

Valeant has had precious little to be happy about over the last few years, it’s bounced from one piece of …

bacteria-1959386_960_720

Gut bacteria may be key to efficacy of immunotherapies

November 6, 2017
Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …

smartphone-1957740_960_720

NHS to offer GP appointments via smartphone

November 6, 2017
Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical

It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …

novartis_hq_day

Novartis aims for CAR-T double-approval in Europe

November 6, 2017
Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical

Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …

The Gateway to Local Adoption Series

Latest content